Form 4: Encompass Health CEO Mark Tarr Reports Stock Transaction
SEC Form 4 Filing
Encompass Health's CEO, Mark Tarr, reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock vesting.
Summary
- Mark J. Tarr, President & CEO of Encompass Health Corp, reported a transaction on February 28, 2025.
- The transaction involved the withholding of 2,187 shares of Encompass Health Common Stock at a price of $100.14 per share to cover tax obligations.
- Following the transaction, Tarr directly owns 527,070 shares of Encompass Health Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a standard transaction related to tax obligations.
Industry Context
This is a routine Form 4 filing, which is common for corporate insiders who have transactions in their company's stock. It provides transparency into the trading activities of key personnel.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of the stock transaction (withholding of shares). |
| 03/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.